Aoxing Pharmaceutical Company's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Aoxing Pharmaceutical Company is scheduled to report earnings on May 15, 2017, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 17	Dec 16	Sep 16	Jun 16	Mar 16
Income Statement	-
Total Revenue	$ 5.70M	$ 8.01M	$ 7.57M	$ 8.82M	$ 6.56M
Gross Profit	$ 4.42M	$ 6.30M	$ 6.05M	$ 6.16M	$ 4.93M
EBIT	$ 878.40K	$ 250.54K	$ 1.70M	$ -1.85M	$ 1.53M
EBITDA	$ 1.12M	$ 502.70K	$ 1.95M	$ -1.60M	$ 1.78M
Net Income Common Stockholders	$ 132.14K	$ -43.45K	$ 346.08K	$ -1.90M	$ 622.72K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 7.08M	$ 6.85M	$ 7.06M	$ 6.91M	$ 6.05M
Total Assets	$ 62.47M	$ 58.72M	$ 58.77M	$ 56.23M	$ 58.93M
Total Debt	$ 27.72M	$ 24.39M	$ 25.39M	$ 25.47M	$ 26.58M
Net Debt	$ 20.64M	$ 17.54M	$ 18.34M	$ 18.56M	$ 20.53M
Total Liabilities	$ 44.38M	$ 40.92M	$ 40.26M	$ 38.16M	$ 38.38M
Stockholders Equity	$ 19.11M	$ 18.84M	$ 19.53M	$ 19.14M	$ 21.52M
Cash Flow	-
Free Cash Flow	$ -3.02M	$ 81.29K	$ 132.81K	$ 1.41M	$ -1.26M
Operating Cash Flow	$ -3.02M	$ 87.94K	$ 134.94K	$ 1.43M	$ -1.25M
Investing Cash Flow	$ -80.00	$ -6.64K	$ -2.13K	$ -21.41K	$ -5.94K
Financing Cash Flow	$ 3.18M	$ 0.00	$ 0.00	$ -320.98K	$ 402.94K

Currency in USD

Aoxing Pharmaceutical Company Earnings and Revenue History

Income Statement >

Aoxing Pharmaceutical Company Debt to Assets

Balance Sheet >

Aoxing Pharmaceutical Company Cash Flow

Cash Flow >

Aoxing Pharmaceutical Company Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing